Determines prone positioning eligibility based on PROSEVA trial criteria (P/F<150, PEEP≥5, FiO2≥0.6) and provides contraindication checklist, expected P/F improvement calculation, and safe proning protocol.
BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).
BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.
Determines prone positioning eligibility based on PROSEVA trial criteria (P/F<150, PEEP≥5, FiO2≥0.6) and provides contraindication checklist, expected P/F improvement calculation, and safe proning protocol
Each component has a specific meaning:
Note: Interpret the prone positioning ards result against the clinical thresholds and context described above.
Enter the PROSEVA trial criteria (P/F<150, PEEP≥5, FiO2≥0 for the patient or scenario you are assessing. Determines prone positioning eligibility based on PROSEVA trial criteria (P/F<150, PEEP≥5, FiO2≥0.6) and provides contraindication checklist, expected P/F improvement calculation, and safe proning protocol. Use the prone positioning ards result to inform your clinical assessment.